发明名称 |
FUSED HETEROCYCLIC DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE THEREOF |
摘要 |
<p>A fused heterocyclic derivative represented by the general formula (I) (wherein R<1> is hydrogen, OH, etc.; R<2> is hydrogen, halogeno, or alkyl; R<3> and R<4> each is hydrogen, OH, halogeno, etc.; Q is alkylene, etc.; ring A is aryl or heteroaryl; and G is the group represented by the formula (G1) or (G2)), (G1) (G2) a pharmacologically acceptable salt of the derivative, or a prodrug of either. They have excellent inhibitory activity against human SGLT and are useful as preventive or therapeutic agents for diseases attributable to hyperglycemia, such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, complications of diabetes, and obesity.</p> |
申请公布号 |
WO2004087727(A1) |
申请公布日期 |
2004.10.14 |
申请号 |
WO2004JP04009 |
申请日期 |
2004.03.24 |
申请人 |
KISSEI PHARMACEUTICAL CO., LTD.;FUSHIMI, NOBUHIKO;YONEKUBO, SHIGERU;MURANAKA, HIDEYUKI;SHIOHARA, HIROAKI;TERANISHI, HIROTAKA;SHIMIZU, KAZUO;ITO, FUMIAKI;ISAJI, MASAYUKI |
发明人 |
FUSHIMI, NOBUHIKO;YONEKUBO, SHIGERU;MURANAKA, HIDEYUKI;SHIOHARA, HIROAKI;TERANISHI, HIROTAKA;SHIMIZU, KAZUO;ITO, FUMIAKI;ISAJI, MASAYUKI |
分类号 |
A61K31/7036;A61K31/7042;A61K31/7048;A61K31/7056;A61K31/706;A61P3/04;A61P3/06;A61P3/10;A61P9/12;A61P7/10;A61P9/04;A61P9/10;A61P19/06;A61P43/00;C07H15/203;C07H17/00;C07H17/02;C07H17/04;(IPC1-7):C07H15/203;A61K31/703;A61K31/704;A61K31/705 |
主分类号 |
A61K31/7036 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|